Universitas Sebelas Maret
Quick facts
Marketed products
- Hyperbaric Lidocaine 5%
- Oral lumbrokinase DLBS1033 · Cardiovascular
Lumbrokinase is a fibrinolytic enzyme derived from earthworm that breaks down fibrin clots and improves blood flow.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Universitas Sebelas Maret
What are Universitas Sebelas Maret's marketed drugs?
Top marketed products include Hyperbaric Lidocaine 5%, Oral lumbrokinase DLBS1033.
Related
- Hyperbaric Lidocaine 5%
- Oral lumbrokinase DLBS1033 · Cardiovascular
- Sector hub: All tracked pharma companies